Skip to main content

Johnson & Johnson(JNJ-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low179.06
Day High181.55
Open:180.53
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest News

FILE - In this Feb. 19, 2019, file photo, West Virginia Attorney General Patrick Morrisey speaks at a news conference in Martinsburg, W.Va. Attorneys for the state of West Virginia and two remaining pharmaceutical manufacturers have reached a tentative $161.5 million settlement just as closing arguments were set to begin in a seven-week trial over the opioid epidemic, Attorney General Patrick Morrisey said Wednesday, May 25, 2022. (Matthew Umstead/The Herald-Mail via AP, File)
Tentative $161.5M settlement reached in WVa opioid trial
Associated Press - Wed May 25, 10:18AM CDT
Associated Press
Wed May 25, 10:18AM CDT
CHARLESTON, W.Va. (AP) — Attorneys for the state of West Virginia and two remaining pharmaceutical manufacturers have reached a tentative $161.5 million settlement just as closing arguments were set to begin in a seven-week trial over the opioid epidemic, Attorney General Patrick Morrisey said Wednesday.
2 Top Biotech Stocks to Buy in May
Motley Fool - Wed May 25, 9:15AM CDT
Motley Fool
Wed May 25, 9:15AM CDT
Despite the market sell-off, these biotech stocks have held up exceptionally well.
Healthcare - stethescope with cartoon heart
2 Covered Call Ideas on Johnson & Johnson Stock
Barchart - Tue May 24, 6:31PM CDT
Barchart
Tue May 24, 6:31PM CDT
With markets looking increasingly volatile, investors might be more interested in generating income rather than capital gains. Johnson & Johnson (JNJ) is a solid defensive play that has held up well so far this year. JNJ also pays a healthy dividend with the current dividend yield sitting at 2.40%.

Latest Articles